EP Patent

EP3601249A1 — Methods for treating hematological malignancies and ewing's sarcoma

Assigned to Kura Oncology Inc · Expires 2020-02-05 · 6y expired

What this patent protects

The present disclosure provides methods for treating hematological malignancies and Ewings sarcoma using menin inhibitors. Compositions for use in these methods are also provided.

USPTO Abstract

The present disclosure provides methods for treating hematological malignancies and Ewings sarcoma using menin inhibitors. Compositions for use in these methods are also provided.

Drugs covered by this patent

Patent Metadata

Patent number
EP3601249A1
Jurisdiction
EP
Classification
—
Expires
2020-02-05
Drug substance claim
No
Drug product claim
No
Assignee
Kura Oncology Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.